FGFR2 and lung cancer: The reason for the disparate results between lung and endometrial cancer models is unknown but could be due to higher expression of Mcl‐1 in lung cancers and/or differences in other prosurvival/pro‐apoptotic proteins regulated by FGFR1 and FGFR2.